OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
Kazuhiko Yamada, Yusaku Hori, Satoshi Inoue, et al.
Cancer Research (2021) Vol. 81, Iss. 4, pp. 1052-1062
Open Access | Times Cited: 43
Kazuhiko Yamada, Yusaku Hori, Satoshi Inoue, et al.
Cancer Research (2021) Vol. 81, Iss. 4, pp. 1052-1062
Open Access | Times Cited: 43
Showing 1-25 of 43 citing articles:
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
Jiaqi Liu, Qing Xiao, Jiani Xiao, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 1221
Jiaqi Liu, Qing Xiao, Jiani Xiao, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 1221
WNT as a Driver and Dependency in Cancer
Marie J. Parsons, Tuomas Tammela, Lukas E. Dow
Cancer Discovery (2021) Vol. 11, Iss. 10, pp. 2413-2429
Open Access | Times Cited: 111
Marie J. Parsons, Tuomas Tammela, Lukas E. Dow
Cancer Discovery (2021) Vol. 11, Iss. 10, pp. 2413-2429
Open Access | Times Cited: 111
WNT signaling and cancer stemness
Masuko Katoh, Masaru Katoh
Essays in Biochemistry (2022) Vol. 66, Iss. 4, pp. 319-331
Open Access | Times Cited: 94
Masuko Katoh, Masaru Katoh
Essays in Biochemistry (2022) Vol. 66, Iss. 4, pp. 319-331
Open Access | Times Cited: 94
Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets
Greta Pessino, Claudia Scotti, Maristella Maggi
Cancers (2024) Vol. 16, Iss. 5, pp. 901-901
Open Access | Times Cited: 19
Greta Pessino, Claudia Scotti, Maristella Maggi
Cancers (2024) Vol. 16, Iss. 5, pp. 901-901
Open Access | Times Cited: 19
Transcriptomic Profiling of MSI-H/dMMR Gastrointestinal Tumors to Identify Determinants of Responsiveness to Anti–PD-1 Therapy
Keigo Chida, Akihito Kawazoe, Toshihiro Suzuki, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 10, pp. 2110-2117
Open Access | Times Cited: 48
Keigo Chida, Akihito Kawazoe, Toshihiro Suzuki, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 10, pp. 2110-2117
Open Access | Times Cited: 48
Protein lysine acetyltransferase CBP/p300: A promising target for small molecules in cancer treatment
Panhong Gou, Wenchao Zhang
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116130-116130
Open Access | Times Cited: 11
Panhong Gou, Wenchao Zhang
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116130-116130
Open Access | Times Cited: 11
Next-Generation Immunotherapy for Hepatocellular Carcinoma: Mechanisms of Resistance and Novel Treatment Approaches
Shabnam Eghbali, Thatcher Heumann
Cancers (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access | Times Cited: 1
Shabnam Eghbali, Thatcher Heumann
Cancers (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access | Times Cited: 1
Tumor-agnostic drug development in dMMR/MSI-H solid tumors
Deepak Bhamidipati, Vivek Subbiah
Trends in cancer (2023) Vol. 9, Iss. 10, pp. 828-839
Open Access | Times Cited: 20
Deepak Bhamidipati, Vivek Subbiah
Trends in cancer (2023) Vol. 9, Iss. 10, pp. 828-839
Open Access | Times Cited: 20
Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma
Masahiro Morita, Naoshi Nishida, Tomoko Aoki, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2311-2311
Open Access | Times Cited: 18
Masahiro Morita, Naoshi Nishida, Tomoko Aoki, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2311-2311
Open Access | Times Cited: 18
The β-catenin C terminus links Wnt and sphingosine-1-phosphate signaling pathways to promote vascular remodeling and atherosclerosis
Gustavo H. Oliveira‐Paula, Sophia Liu, Alishba Maira, et al.
Science Advances (2024) Vol. 10, Iss. 11
Open Access | Times Cited: 6
Gustavo H. Oliveira‐Paula, Sophia Liu, Alishba Maira, et al.
Science Advances (2024) Vol. 10, Iss. 11
Open Access | Times Cited: 6
Diastereo‐ and Enantioselective Silver‐Catalyzed [3+3] Cycloaddition and Kinetic Resolution of Azomethine Imines with Activated Isocyanides
Ling‐Fei Tao, Sen Zhang, Fen Huang, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 23
Closed Access | Times Cited: 23
Ling‐Fei Tao, Sen Zhang, Fen Huang, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 23
Closed Access | Times Cited: 23
Why Is Wnt/β-Catenin Not Yet Targeted in Routine Cancer Care?
Auriane de Pellegars-Malhortie, Laurence Picque Lasorsa, Thibault Mazard, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 949-949
Open Access | Times Cited: 5
Auriane de Pellegars-Malhortie, Laurence Picque Lasorsa, Thibault Mazard, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 949-949
Open Access | Times Cited: 5
Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response
Kai Wang, Chao Yang, Haibin Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Kai Wang, Chao Yang, Haibin Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Oncofetal proteins and cancer stem cells
Qian Yan, Xiaona Fang, Chenxi Li, et al.
Essays in Biochemistry (2022) Vol. 66, Iss. 4, pp. 423-433
Closed Access | Times Cited: 19
Qian Yan, Xiaona Fang, Chenxi Li, et al.
Essays in Biochemistry (2022) Vol. 66, Iss. 4, pp. 423-433
Closed Access | Times Cited: 19
Mechanisms and biomarkers of immune-related adverse events in gastric cancer
Pingan Ding, Pengpeng Liu, Lingjiao Meng, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 11
Pingan Ding, Pengpeng Liu, Lingjiao Meng, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 11
Wnt signaling in gastric cancer: current progress and future prospects
Ruyue Han, Jing Yang, Yingying Zhu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Ruyue Han, Jing Yang, Yingying Zhu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Decoding Genomic Diversity to Guide Tumor Lesion‐Specific Treatment of Multifocal Hepatocellular Carcinoma
Kenji Amemiya, Yosuke Hirotsu, Yuji Iimuro, et al.
Cancer Medicine (2025) Vol. 14, Iss. 7
Open Access
Kenji Amemiya, Yosuke Hirotsu, Yuji Iimuro, et al.
Cancer Medicine (2025) Vol. 14, Iss. 7
Open Access
Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances
Xue Chen, Qingfei Chu, Qingmiao Shi, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Xue Chen, Qingfei Chu, Qingmiao Shi, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Randomized study evaluating optimal dose, efficacy, and safety of E7386 plus lenvatinib versus treatment of physician’s choice in advanced/recurrent endometrial carcinoma previously treated with platinum-based chemotherapy and immune checkpoint inhibitors
Ramez N. Eskander, Jung‐Yun Lee, Mansoor Raza Mirza, et al.
International Journal of Gynecological Cancer (2025), pp. 101812-101812
Closed Access
Ramez N. Eskander, Jung‐Yun Lee, Mansoor Raza Mirza, et al.
International Journal of Gynecological Cancer (2025), pp. 101812-101812
Closed Access
Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma
María San Román, Javier Torres-Jiménez, Javier Pozas, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 863-863
Open Access | Times Cited: 10
María San Román, Javier Torres-Jiménez, Javier Pozas, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 863-863
Open Access | Times Cited: 10
The Usher syndrome 1C protein harmonin regulates canonical Wnt signaling
Jessica Schäfer, Nicole Wenck, Katharina Janik, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 8
Jessica Schäfer, Nicole Wenck, Katharina Janik, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 8
Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective
Yongquan Tang, Yan Chen, Zhe Zhang, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2116-2116
Open Access | Times Cited: 18
Yongquan Tang, Yan Chen, Zhe Zhang, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2116-2116
Open Access | Times Cited: 18
Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience
Keita Ogawa, Hiroaki Kanzaki, Tetsuhiro Chiba, et al.
Journal of Cancer (2022) Vol. 13, Iss. 8, pp. 2656-2661
Open Access | Times Cited: 13
Keita Ogawa, Hiroaki Kanzaki, Tetsuhiro Chiba, et al.
Journal of Cancer (2022) Vol. 13, Iss. 8, pp. 2656-2661
Open Access | Times Cited: 13
Targeting the Wnt/β-catenin signal pathway for the treatment of gastrointestinal cancer: Potential for advancement
Xizhi Jin, Sijie Wang, Lihua Luo, et al.
Biochemical Pharmacology (2024) Vol. 227, pp. 116463-116463
Closed Access | Times Cited: 2
Xizhi Jin, Sijie Wang, Lihua Luo, et al.
Biochemical Pharmacology (2024) Vol. 227, pp. 116463-116463
Closed Access | Times Cited: 2
Specific features of ß-catenin-mutated hepatocellular carcinomas
Camille Dantzer, Lydia Dif, Justine Vaché, et al.
British Journal of Cancer (2024)
Open Access | Times Cited: 2
Camille Dantzer, Lydia Dif, Justine Vaché, et al.
British Journal of Cancer (2024)
Open Access | Times Cited: 2
